| Literature DB >> 27708644 |
Jinbiao Liu1, Qianhao Xiao1, Runhong Zhou1, Yong Wang1, Qiaoyang Xian1, Tongcui Ma1, Ke Zhuang1, Li Zhou1, Deyin Guo2, Xu Wang2, Wen-Zhe Ho3, Jieliang Li2.
Abstract
Altered T-cell homeostasis, such as expansion of CD8+ T cells to the secondary lymphatic compartments, has been suggested as a mechanism of HIV/simian immunodeficiency virus (SIV)-pathogenesis. However, the role of immune activation of CD8+ T cells in the CD4/CD8 turnover and viral replication in these tissues is not completely understood. In this study, we compared the expression of immune activation markers (CD69 and HLA-DR) on CD8+ T cells in the peripheral blood and lymph nodes (LNs) of SIV-infected/uninfected Chinese rhesus macaques. SIV-infected macaques had significantly higher percentages of CD8+CD69+ and CD8+HLA-DR+ T cells in all these anatomical compartments than uninfected macaques. LNs that located close to the gastrointestinal (GI) tract (colon, mesenteric, and iliac LNs) of SIV-infected macaques had profoundly lower numbers of CD4+ T cells, but no significant difference in expression of activation marker (CD8+CD69+ and CD8+HLA-DR+) as compared with the peripheral lymphatic tissues (axillary and inguinal LNs). The CD4/CD8 ratios were negatively correlated with the activation of CD8+ T cells in the overall LNs, with further associations with CD8+HLA-DR+ in GI LNs while CD8+CD69+ in peripheral LNs. These observations demonstrate that the increase of CD8+ T cell activation is a contributing factor for the decline of CD4/CD8 ratios in GI system.Entities:
Keywords: CD4/CD8 ratio; CD8 activation; immune activation; lymph nodes; simian immunodeficiency virus
Year: 2016 PMID: 27708644 PMCID: PMC5030343 DOI: 10.3389/fimmu.2016.00371
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Animals involved in this study and specimen information.
| Animal ID | SIV strain | Inoculation route | Times of necropsy | Death complications | Plasma viral load | CD4/CD8 ratio | Lymph nodes | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Axillary | Inguinal | Salivary | Paratracheal | Adrenal | Carinal | Gastric | Duodenal | Jejunum | Iliac | Cecal | Colon | Mesentery | Celiac | Pelvic | IELs | Blood | Spleen | Plasma | |||||||
| WSN01 | SIVmacR71/17E | i.v. | 83 W | NeuroAIDS | 3.48E + 07 | 0.18 | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
| WSN03 | SIVmacR71/17E | i.v. | 173 W | Diarrhea | 7.16E + 07 | 1.61 | √ | √ | √ | √ | √ | √ | |||||||||||||
| WSN04 | SIVmacR71/17E | i.v. | 174 W | Diarrhea | 2.03E + 06 | 0.17 | √ | √ | √ | √ | √ | √ | |||||||||||||
| WSP03 | SIVmac251 | i.v. | 200 W | Diarrhea | 2.97E + 07 | 0.50 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||
| WSB02 | SIVmac239 | i.v. | 33 W | Unknown | 2.36E + 09 | √ | √ | √ | √ | ||||||||||||||||
| WSL03 | SIVmac239 | i.v. | 150 W | Diarrhea | 9.64E + 07 | 0.07 | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||||
| WSL04 | SIVmac239 | i.v. | 183 W | Diarrhea | 2.86E + 07 | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
| WSL05 | SIVmac239 | i.v. | 181 W | Diarrhea | 7.35E + 07 | 1.39 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||
| WSP08 | SIVmac239 | i.v. | 125 W | Diarrhea | 8.34E + 08 | 0.12 | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| WSP09 | SIVmac239 | i.v. | 128 W | Tumor | 4.65E + 07 | 0.5 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||
| WSP11 | SIVmac239 | i.vag. | 149 W | Diarrhea | 2.45E + 07 | 0.94 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||
| WSP12 | SIVmac239 | i.vag. | 216 W | Diarrhea | 4.02E + 07 | 0.7 | √ | √ | √ | √ | √ | √ | |||||||||||||
| HK01 | None | None | 0.91 | √ | √ | √ | √ | ||||||||||||||||||
| WSE01 | None | None | 1.74 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| T096041 | None | None | 2.03 | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||||||||
| T096057 | None | None | 1.15 | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||||||||
| T106027 | None | None | 0.82 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10341 | None | None | 1.05 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10025 | None | None | 1.27 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10409 | None | None | 0.81 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10013 | None | None | 1.00 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10045 | None | None | 0.96 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
| 10343 | None | None | 0.82 | √ | √ | √ | √ | √ | √ | √ | |||||||||||||||
.
.
.
IELs, intraepithelial lymphocytes.
Figure 1Plasma SIV load and CD4/CD8 ratio in SIV-infected Chinese rhesus macaques. Twelve animals were i.v. or i.vag. inoculated with different strains of SIV as indicated in Table 1. (A) The plasma viral load in individual animal was monitored. (B) Mean values of plasma viral load in the SIV-infected macaques. (C) CD4/CD8 ratio in individual animal was monitored. (D) Mean values of CD4/CD8 ratios in the SIV-infected macaques.
Figure 2Effect of SIV infection on the depletion of CD4. (A) CD4+ T cell percentages in the blood, inguinal LN, and colon LN of one uninfected macaques (T096057) and four SIV-infected macaques (WSP09, WSN01, WSP11, and WSL03). (B) Statistical analysis of CD4+ T cell percentages in the blood, peripheral LNs, and GI LNs of SIV-infected and -uninfected macaques. (C) Statistical analysis of CD4/CD8 ratio in the blood, peripheral LNs, and GI LNs of SIV-infected and -uninfected macaques. N means the number of specimens. The “n” represents the number of specimens from all monkeys involved in this study.
Figure 3Effect of SIV infection on the depletion of CD4. (A) Flow cytometric analysis of CD4+ and CD8+ T cells in IEL from one uninfected and four SIV-infected macaques. Approximately 6–10 cm long pieces of jejunum and colon were collected from SIV-infected or -uninfected macaques at necropsy. (B) Statistical analysis of CD4+ T cell percentages in jejunum and colon IEL of SIV-infected (N = 6) and -uninfected macaques (N = 10). (C) Statistical analysis of CD4/CD8 ratio in jejunum and colon IEL of SIV-infected (N = 6) and -uninfected macaques (N = 10).
Figure 4T cells activation in different tissues of SIV-infected and -uninfected rhesus macaques. Statistical analysis of activation marker CD69 and HLA-DR expression on CD4+ (A,B) and CD8+ (C,D) T cells in different tissues of SIV end-staged infected and uninfected rhesus macaques. N means the number of specimens.
Figure 5Correlation analysis of the activation of CD4. (A) The percentage of CD4+CD69+ had no association with CD4/CD8 ratio. (B) The percentage of CD8+CD69+ was negatively correlated with CD4/CD8 ratio. (C) The percentage of CD4+HLA-DR+ was positively associated with CD4/CD8 ratio. (D) The percentage of CD8+HLA-DR+ was negatively correlated with CD4/CD8 ratio.
Figure 6SIV load and TNF-α level in the peripheral LNs and GI LNs of SIV-infected monkeys. The LNs were collected from monkeys at necropsy, and total RNA was extracted. The expression of SIV gag (A) and TNF-α (B) was measured by quantitative RT-PCR. These data were normalized to the expression of GAPDH.